nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—NR3C2—dilated cardiomyopathy	0.766	1	CbGaD
Spironolactone—ABCC2—Furosemide—dilated cardiomyopathy	0.0909	0.649	CbGbCtD
Spironolactone—ABCB1—Lisinopril—dilated cardiomyopathy	0.0493	0.351	CbGbCtD
Spironolactone—NR3C2—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.00614	0.113	CbGpPWpGaD
Spironolactone—CYP11B2—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.00502	0.0928	CbGpPWpGaD
Spironolactone—CYP11B2—ACE Inhibitor Pathway—NR3C2—dilated cardiomyopathy	0.00391	0.0721	CbGpPWpGaD
Spironolactone—NR3C2—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.00258	0.0476	CbGpPWpGaD
Spironolactone—NR3C2—ACE Inhibitor Pathway—ACE—dilated cardiomyopathy	0.0022	0.0407	CbGpPWpGaD
Spironolactone—CYP11B2—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.00211	0.039	CbGpPWpGaD
Spironolactone—NR3C2—ACE Inhibitor Pathway—AGTR1—dilated cardiomyopathy	0.00198	0.0366	CbGpPWpGaD
Spironolactone—Drug eruption—Furosemide—dilated cardiomyopathy	0.0019	0.06	CcSEcCtD
Spironolactone—CYP11B2—ACE Inhibitor Pathway—ACE—dilated cardiomyopathy	0.0018	0.0332	CbGpPWpGaD
Spironolactone—CYP11B2—ACE Inhibitor Pathway—AGTR1—dilated cardiomyopathy	0.00162	0.03	CbGpPWpGaD
Spironolactone—Eplerenone—NR3C2—dilated cardiomyopathy	0.00157	0.31	CrCbGaD
Spironolactone—Drospirenone—NR3C2—dilated cardiomyopathy	0.00151	0.297	CrCbGaD
Spironolactone—Fludrocortisone—NR3C2—dilated cardiomyopathy	0.00142	0.279	CrCbGaD
Spironolactone—NR3C2—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.0014	0.0258	CbGpPWpGaD
Spironolactone—SHBG—Nongenotropic Androgen signaling—RAC1—dilated cardiomyopathy	0.00135	0.025	CbGpPWpGaD
Spironolactone—PGR—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.00121	0.0223	CbGpPWpGaD
Spironolactone—Vasculitis—Furosemide—dilated cardiomyopathy	0.0012	0.0378	CcSEcCtD
Spironolactone—CYP11B2—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.00114	0.0211	CbGpPWpGaD
Spironolactone—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00107	0.0339	CcSEcCtD
Spironolactone—Breast pain—Lisinopril—dilated cardiomyopathy	0.001	0.0317	CcSEcCtD
Spironolactone—ABCC2—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00098	0.0181	CbGpPWpGaD
Spironolactone—AR—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000921	0.017	CbGpPWpGaD
Spironolactone—PGR—Nuclear signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.000911	0.0168	CbGpPWpGaD
Spironolactone—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000898	0.0284	CcSEcCtD
Spironolactone—SHBG—Nongenotropic Androgen signaling—RAF1—dilated cardiomyopathy	0.000898	0.0166	CbGpPWpGaD
Spironolactone—Lethargy—Furosemide—dilated cardiomyopathy	0.000866	0.0273	CcSEcCtD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.000862	0.0159	CbGpPWpGaD
Spironolactone—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000861	0.0272	CcSEcCtD
Spironolactone—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000764	0.0241	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000764	0.0241	CcSEcCtD
Spironolactone—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000726	0.0229	CcSEcCtD
Spironolactone—NR3C1—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000698	0.0129	CbGpPWpGaD
Spironolactone—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000689	0.0218	CcSEcCtD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.000654	0.0121	CbGpPWpGaD
Spironolactone—Drowsiness—Furosemide—dilated cardiomyopathy	0.000654	0.0206	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000648	0.0205	CcSEcCtD
Spironolactone—Renal failure—Furosemide—dilated cardiomyopathy	0.000643	0.0203	CcSEcCtD
Spironolactone—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00061	0.0193	CcSEcCtD
Spironolactone—Ataxia—Lisinopril—dilated cardiomyopathy	0.000598	0.0189	CcSEcCtD
Spironolactone—Progesterone—NR3C2—dilated cardiomyopathy	0.00058	0.114	CrCbGaD
Spironolactone—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000573	0.0181	CcSEcCtD
Spironolactone—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000573	0.0181	CcSEcCtD
Spironolactone—Gastritis—Lisinopril—dilated cardiomyopathy	0.000563	0.0178	CcSEcCtD
Spironolactone—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000555	0.0175	CcSEcCtD
Spironolactone—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000545	0.0172	CcSEcCtD
Spironolactone—AR—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000543	0.01	CbGpPWpGaD
Spironolactone—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000507	0.016	CcSEcCtD
Spironolactone—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000491	0.0155	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000486	0.0154	CcSEcCtD
Spironolactone—Renal failure—Lisinopril—dilated cardiomyopathy	0.000482	0.0152	CcSEcCtD
Spironolactone—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000461	0.00851	CbGpPWpGaD
Spironolactone—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000458	0.0145	CcSEcCtD
Spironolactone—Leukopenia—Furosemide—dilated cardiomyopathy	0.000457	0.0144	CcSEcCtD
Spironolactone—Confusional state—Furosemide—dilated cardiomyopathy	0.00042	0.0133	CcSEcCtD
Spironolactone—AR—Nongenotropic Androgen signaling—RAC1—dilated cardiomyopathy	0.000419	0.00774	CbGpPWpGaD
Spironolactone—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000417	0.0132	CcSEcCtD
Spironolactone—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000416	0.0132	CcSEcCtD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000412	0.00761	CbGpPWpGaD
Spironolactone—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000408	0.0129	CcSEcCtD
Spironolactone—Alopecia—Lisinopril—dilated cardiomyopathy	0.000389	0.0123	CcSEcCtD
Spironolactone—AR—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000387	0.00714	CbGpPWpGaD
Spironolactone—CYP11B2—heart—dilated cardiomyopathy	0.000377	0.144	CbGeAlD
Spironolactone—Somnolence—Furosemide—dilated cardiomyopathy	0.000371	0.0117	CcSEcCtD
Spironolactone—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000368	0.0116	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00036	0.0114	CcSEcCtD
Spironolactone—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000356	0.0112	CcSEcCtD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—GJA1—dilated cardiomyopathy	0.00035	0.00646	CbGpPWpGaD
Spironolactone—Malaise—Lisinopril—dilated cardiomyopathy	0.000346	0.0109	CcSEcCtD
Spironolactone—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000344	0.0109	CcSEcCtD
Spironolactone—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000343	0.0108	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	0.00034	0.00629	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00034	0.00627	CbGpPWpGaD
Spironolactone—Urticaria—Furosemide—dilated cardiomyopathy	0.000331	0.0105	CcSEcCtD
Spironolactone—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00033	0.0104	CcSEcCtD
Spironolactone—Discomfort—Lisinopril—dilated cardiomyopathy	0.000322	0.0102	CcSEcCtD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00032	0.00591	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000319	0.0059	CbGpPWpGaD
Spironolactone—Confusional state—Lisinopril—dilated cardiomyopathy	0.000315	0.00996	CcSEcCtD
Spironolactone—PGR—Cellular roles of Anthrax toxin—TNF—dilated cardiomyopathy	0.000314	0.00579	CbGpPWpGaD
Spironolactone—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000313	0.00988	CcSEcCtD
Spironolactone—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000307	0.0097	CcSEcCtD
Spironolactone—PGR—Signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.000307	0.00566	CbGpPWpGaD
Spironolactone—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000306	0.00967	CcSEcCtD
Spironolactone—Pruritus—Furosemide—dilated cardiomyopathy	0.000295	0.00932	CcSEcCtD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000294	0.00542	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000293	0.00541	CbGpPWpGaD
Spironolactone—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000285	0.00901	CcSEcCtD
Spironolactone—Somnolence—Lisinopril—dilated cardiomyopathy	0.000278	0.00878	CcSEcCtD
Spironolactone—AR—Nongenotropic Androgen signaling—RAF1—dilated cardiomyopathy	0.000278	0.00513	CbGpPWpGaD
Spironolactone—Dizziness—Furosemide—dilated cardiomyopathy	0.000276	0.00871	CcSEcCtD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000275	0.00508	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00027	0.00853	CcSEcCtD
Spironolactone—Vomiting—Furosemide—dilated cardiomyopathy	0.000265	0.00837	CcSEcCtD
Spironolactone—Rash—Furosemide—dilated cardiomyopathy	0.000263	0.0083	CcSEcCtD
Spironolactone—Dermatitis—Furosemide—dilated cardiomyopathy	0.000263	0.0083	CcSEcCtD
Spironolactone—Headache—Furosemide—dilated cardiomyopathy	0.000261	0.00825	CcSEcCtD
Spironolactone—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000258	0.00814	CcSEcCtD
Spironolactone—NR3C2—cardiac ventricle—dilated cardiomyopathy	0.000253	0.0966	CbGeAlD
Spironolactone—Urticaria—Lisinopril—dilated cardiomyopathy	0.000248	0.00785	CcSEcCtD
Spironolactone—Nausea—Furosemide—dilated cardiomyopathy	0.000248	0.00782	CcSEcCtD
Spironolactone—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000247	0.00781	CcSEcCtD
Spironolactone—NR3C2—myocardium—dilated cardiomyopathy	0.000238	0.0909	CbGeAlD
Spironolactone—SLCO1A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000238	0.0044	CbGpPWpGaD
Spironolactone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00023	0.00728	CcSEcCtD
Spironolactone—PGR—myocardium—dilated cardiomyopathy	0.000221	0.0845	CbGeAlD
Spironolactone—Pruritus—Lisinopril—dilated cardiomyopathy	0.000221	0.00699	CcSEcCtD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	0.000221	0.00409	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	0.000218	0.00402	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000215	0.00397	CbGpPWpGaD
Spironolactone—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000214	0.00676	CcSEcCtD
Spironolactone—PGR—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000209	0.00385	CbGpPWpGaD
Spironolactone—Dizziness—Lisinopril—dilated cardiomyopathy	0.000207	0.00653	CcSEcCtD
Spironolactone—Vomiting—Lisinopril—dilated cardiomyopathy	0.000199	0.00628	CcSEcCtD
Spironolactone—Rash—Lisinopril—dilated cardiomyopathy	0.000197	0.00623	CcSEcCtD
Spironolactone—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000197	0.00622	CcSEcCtD
Spironolactone—Headache—Lisinopril—dilated cardiomyopathy	0.000196	0.00619	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—IL10—dilated cardiomyopathy	0.000189	0.00348	CbGpPWpGaD
Spironolactone—AR—cardiac ventricle—dilated cardiomyopathy	0.000188	0.0715	CbGeAlD
Spironolactone—Nausea—Lisinopril—dilated cardiomyopathy	0.000186	0.00587	CcSEcCtD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000184	0.00339	CbGpPWpGaD
Spironolactone—NR3C1—Transcription factor regulation in adipogenesis—TNF—dilated cardiomyopathy	0.000181	0.00335	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—RAC1—dilated cardiomyopathy	0.00018	0.00333	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	0.000177	0.00326	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—LMNA—dilated cardiomyopathy	0.000176	0.00326	CbGpPWpGaD
Spironolactone—AR—myocardium—dilated cardiomyopathy	0.000176	0.0673	CbGeAlD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000173	0.00319	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	0.000168	0.0031	CbGpPWpGaD
Spironolactone—NR3C2—heart—dilated cardiomyopathy	0.000166	0.0634	CbGeAlD
Spironolactone—AR—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000159	0.00294	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—AGT—dilated cardiomyopathy	0.000158	0.00293	CbGpPWpGaD
Spironolactone—PGR—heart—dilated cardiomyopathy	0.000155	0.059	CbGeAlD
Spironolactone—CYP11B2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000151	0.00279	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000151	0.00279	CbGpPWpGaD
Spironolactone—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000146	0.00269	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—TAZ—dilated cardiomyopathy	0.000142	0.00263	CbGpPWpGaD
Spironolactone—NR3C2—cardiac atrium—dilated cardiomyopathy	0.000142	0.0542	CbGeAlD
Spironolactone—NR3C1—cardiac ventricle—dilated cardiomyopathy	0.000136	0.0518	CbGeAlD
Spironolactone—PGR—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000131	0.00242	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000131	0.00242	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00013	0.00241	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ANKRD1—dilated cardiomyopathy	0.00013	0.00241	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—SDHA—dilated cardiomyopathy	0.000129	0.00238	CbGpPWpGaD
Spironolactone—NR3C1—myocardium—dilated cardiomyopathy	0.000128	0.0487	CbGeAlD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000124	0.0023	CbGpPWpGaD
Spironolactone—AR—heart—dilated cardiomyopathy	0.000123	0.047	CbGeAlD
Spironolactone—CYP11B1—Metabolism—TAZ—dilated cardiomyopathy	0.000123	0.00226	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000121	0.00223	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000121	0.00223	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000121	0.00223	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.000118	0.00218	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000115	0.00212	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000113	0.00209	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000112	0.00208	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—SDHA—dilated cardiomyopathy	0.000111	0.00205	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00011	0.00203	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00011	0.00203	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.00011	0.00203	CbGpPWpGaD
Spironolactone—AR—cardiac atrium—dilated cardiomyopathy	0.000105	0.0402	CbGeAlD
Spironolactone—NR3C2—Gene Expression—NPPA—dilated cardiomyopathy	0.000104	0.00191	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000104	0.00191	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—FAS—dilated cardiomyopathy	0.000103	0.0019	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000102	0.00189	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—RAF1—dilated cardiomyopathy	0.000102	0.00189	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—NR3C2—dilated cardiomyopathy	0.0001	0.00186	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	9.99e-05	0.00184	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	9.99e-05	0.00184	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	9.94e-05	0.00183	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	9.79e-05	0.00181	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—AGT—dilated cardiomyopathy	9.65e-05	0.00178	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	9.2e-05	0.0017	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	9.02e-05	0.00167	CbGpPWpGaD
Spironolactone—NR3C1—heart—dilated cardiomyopathy	8.92e-05	0.034	CbGeAlD
Spironolactone—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	8.55e-05	0.00158	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	8.48e-05	0.00157	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	8.25e-05	0.00152	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—EGFR—dilated cardiomyopathy	8.2e-05	0.00151	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	8.18e-05	0.00151	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.85e-05	0.00145	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	7.69e-05	0.00142	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NR3C2—dilated cardiomyopathy	7.66e-05	0.00141	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.64e-05	0.00141	CbGpPWpGaD
Spironolactone—NR3C1—cardiac atrium—dilated cardiomyopathy	7.63e-05	0.0291	CbGeAlD
Spironolactone—NR3C1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	7.58e-05	0.0014	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—EGFR—dilated cardiomyopathy	7.01e-05	0.0013	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	6.95e-05	0.00128	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.88e-05	0.00127	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.76e-05	0.00125	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.59e-05	0.00122	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	6.49e-05	0.0012	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—NPPA—dilated cardiomyopathy	6.31e-05	0.00117	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.93e-05	0.0011	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NR3C2—dilated cardiomyopathy	5.81e-05	0.00107	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	5.37e-05	0.000992	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.33e-05	0.000983	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.18e-05	0.000957	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.18e-05	0.000957	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	4.98e-05	0.00092	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.82e-05	0.000889	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NPPA—dilated cardiomyopathy	4.81e-05	0.000888	CbGpPWpGaD
Spironolactone—ABCB1—heart—dilated cardiomyopathy	4.77e-05	0.0182	CbGeAlD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	4.45e-05	0.000822	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—TNF—dilated cardiomyopathy	4.38e-05	0.000808	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.24e-05	0.000783	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	4.24e-05	0.000783	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	4.22e-05	0.000779	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.13e-05	0.000763	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	4.07e-05	0.000752	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	4.02e-05	0.000742	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.99e-05	0.000737	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.97e-05	0.000734	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	3.78e-05	0.000698	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	3.78e-05	0.000698	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.72e-05	0.000687	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NPPA—dilated cardiomyopathy	3.65e-05	0.000674	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.53e-05	0.000651	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.53e-05	0.000651	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	3.5e-05	0.000647	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	3.5e-05	0.000646	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GPX1—dilated cardiomyopathy	3.5e-05	0.000645	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	3.42e-05	0.000631	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CD36—dilated cardiomyopathy	3.4e-05	0.000629	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	3.29e-05	0.000608	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.28e-05	0.000606	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.18e-05	0.000587	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AGT—dilated cardiomyopathy	3.06e-05	0.000566	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GPX1—dilated cardiomyopathy	3.01e-05	0.000556	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.98e-05	0.00055	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CD36—dilated cardiomyopathy	2.93e-05	0.000542	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.71e-05	0.000501	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.65e-05	0.000489	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AGT—dilated cardiomyopathy	2.64e-05	0.000488	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.57e-05	0.000475	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.45e-05	0.000453	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.23e-05	0.000413	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.21e-05	0.000408	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.08e-05	0.000385	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.03e-05	0.000375	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RAC1—dilated cardiomyopathy	2e-05	0.000369	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AGT—dilated cardiomyopathy	1.91e-05	0.000353	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	1.89e-05	0.000349	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	1.84e-05	0.00034	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.83e-05	0.000337	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.81e-05	0.000335	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.73e-05	0.000319	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	1.66e-05	0.000306	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RAF1—dilated cardiomyopathy	1.32e-05	0.000245	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.05e-05	0.000194	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	9.28e-06	0.000171	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGFR—dilated cardiomyopathy	9.09e-06	0.000168	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	9.04e-06	0.000167	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	8.14e-06	0.00015	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	8.09e-06	0.000149	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CD36—dilated cardiomyopathy	7.87e-06	0.000145	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AGT—dilated cardiomyopathy	7.09e-06	0.000131	CbGpPWpGaD
